Iqvia Holdings IQV
NYSE IQV
$269.47 +0.65 (+0.24%)
As of: Sep 17, 2026 · 3:59 PM EDT

Iqvia Holdings (IQV) Cash from Operations (2012 - 2026)

Iqvia Holdings' (IQV) quarterly Cash from Operations came in at $558.0 million in Q2 2026, up 25.96% year-over-year from $443.0 million in Q2 2025, and down 9.71% quarter-over-quarter from $618.0 million in Q1 2026.

Analysis

Iqvia Holdings (IQV) Cash from Operations (2012 - 2026) Analysis & Trends

Iqvia Holdings has disclosed Cash from Operations across 15 years of filings, most recently posting $558.0 million for Q2 2026.

  • In Q2 2026, Cash from Operations rose 25.96% year-over-year to $558.0 million; the TTM figure through Jun 2026 stood at $2.8 billion (up 7.72% YoY), while the FY2025 annual figure was $2.7 billion, down 2.28% from the prior year.
  • Cash from Operations came in at $558.0 million for Q2 2026 at Iqvia Holdings, down from $618.0 million in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of $908.0 million in Q3 2025 to a low of $329.0 million in Q2 2022.
  • Average Cash from Operations over 5 years is $608.6 million, with a median of $575.5 million recorded in 2023.
  • Year-over-year, Cash from Operations sank 41.41% in 2022 and jumped 46.27% in 2024.
  • Over 5 years, Cash from Operations stood at $560.0 million in 2022, then surged by 33.39% to $747.0 million in 2023, then climbed by 18.47% to $885.0 million in 2024, then fell by 16.95% to $735.0 million in 2025, then retreated by 24.08% to $558.0 million in 2026.
  • Per Business Quant data, the three most recent Cash from Operations figures were $558.0 million in Q2 2026, $618.0 million in Q1 2026, and $735.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 558.00 Mn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 162.01 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 281.27 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 179.73 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 28.90 Mn
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn -44.27 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn -492,000.00
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -2.90 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn - -3.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 558.00 Mn
Mar 31, 2026 618.00 Mn
Dec 31, 2025 735.00 Mn
Sep 30, 2025 908.00 Mn
Jun 30, 2025 443.00 Mn
Mar 31, 2025 568.00 Mn
Dec 31, 2024 885.00 Mn
Sep 30, 2024 721.00 Mn
Jun 30, 2024 588.00 Mn
Mar 31, 2024 522.00 Mn
Dec 31, 2023 747.00 Mn
Sep 30, 2023 583.00 Mn
Jun 30, 2023 402.00 Mn
Mar 31, 2023 417.00 Mn
Dec 31, 2022 560.00 Mn
Sep 30, 2022 863.00 Mn
Jun 30, 2022 329.00 Mn
Mar 31, 2022 508.00 Mn
Dec 31, 2021 692.00 Mn
Sep 30, 2021 844.00 Mn